News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
467,149 Results
Type
Article (17925)
Company Profile (82)
Press Release (449142)
Section
Business (141302)
Career Advice (722)
Deals (26293)
Drug Delivery (80)
Drug Development (56447)
Employer Resources (77)
FDA (13430)
Job Trends (9984)
News (243369)
Policy (23425)
Tag
Academia (913)
Alliances (36864)
Alzheimer's disease (712)
Approvals (13453)
Artificial intelligence (117)
Bankruptcy (210)
Best Places to Work (8114)
Breast cancer (108)
Cancer (1027)
Cardiovascular disease (77)
Career advice (618)
CAR-T (97)
Cell therapy (292)
Clinical research (46730)
Collaboration (470)
Compensation (168)
COVID-19 (1459)
C-suite (106)
Data (1190)
Diabetes (171)
Diagnostics (4288)
Earnings (59779)
Events (66464)
Executive appointments (401)
FDA (14162)
Funding (349)
Gene therapy (188)
GLP-1 (430)
Government (2765)
Healthcare (10791)
Infectious disease (1533)
Interviews (98)
IPO (11870)
Job creations (2224)
Job search strategy (548)
Layoffs (260)
Legal (4694)
Lung cancer (152)
Manufacturing (232)
Medical device (10748)
Medtech (10752)
Mergers & acquisitions (14742)
Metabolic disorders (376)
Neuroscience (950)
NextGen: Class of 2025 (3614)
Non-profit (1223)
Northern California (1423)
Obesity (197)
Opinion (125)
Patents (128)
People (37545)
Phase I (14097)
Phase II (20439)
Phase III (16100)
Pipeline (579)
Postmarket research (1569)
Preclinical (5361)
Radiopharmaceuticals (175)
Rare diseases (190)
Real estate (3955)
Regulatory (17246)
Research institute (900)
Resumes & cover letters (86)
Southern California (1236)
Startups (2290)
United States (12647)
Vaccines (350)
Weight loss (137)
Date
Last 7 days (387)
Last 30 days (1652)
Last 365 days (24219)
2025 (3034)
2024 (24942)
2023 (29094)
2022 (38889)
2021 (41700)
2020 (39678)
2019 (31150)
2018 (23758)
2017 (24606)
2016 (22487)
2015 (26875)
2014 (19414)
2013 (15974)
2012 (17776)
2011 (18440)
2010 (16238)
Location
Africa (396)
Arizona (90)
Asia (30249)
Australia (4849)
California (3214)
Canada (1204)
China (307)
Colorado (139)
Connecticut (153)
Europe (63813)
Florida (474)
Georgia (128)
Illinois (304)
Indiana (204)
Japan (95)
Kansas (77)
Maryland (558)
Massachusetts (2254)
Michigan (192)
Minnesota (207)
New Jersey (1098)
New York (961)
North Carolina (564)
Northern California (1423)
Ohio (118)
Pennsylvania (787)
South America (740)
Southern California (1236)
Texas (430)
Utah (77)
Virginia (85)
Washington State (319)
467,149 Results for "implandata ophthalmic products gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Pharm Country
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today provided an update on its two FDA-approved products.
April 25, 2024
·
10 min read
Press Releases
Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH
January 14, 2025
·
3 min read
Press Releases
Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
February 19, 2025
·
4 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
Press Releases
Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH
November 25, 2024
·
4 min read
Press Releases
U.S. Ophthalmic Drugs Market Size to Hit USD 33.51 Billion by 2033
February 20, 2025
·
1 min read
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
NovaBay Pharmaceuticals, Inc. and Eyenovia, Inc. announced the signing of a co-promotion agreement to commercialize prescription ophthalmic products to eyecare professionals across the U.S. Under the agreement, NovaBay will market Eyenovia’s clobetasol propionate ophthalmic suspension 0.05%, a steroid indicated for the treatment of inflammation and pain following ocular surgery, through its U.S. physician-dispensed channel.
March 13, 2024
·
9 min read
Press Releases
Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)
February 14, 2025
·
2 min read
1 of 46,715
Next
